Curative Biotechnology Inc [Rocket]

In millions, except per share items	Sep-30-22	Jun-30-22	Mar-31-22	Sep-30-21	Jun-30-21	Mar-31-21
	S-1/A	S-1	S-1/A	S-1/A	S-1	S-1/A
Revenues	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0
Selling, general and administrative [+]	0.6	0.4	0.7	0.7	2.5	0.6
General and administrative [+]	0.6	0.4	0.7	0.7	2.5	0.6
General and administrative expenses	0.6	0.4	0.7	0.7	2.5	0.6
Research and development	0.5	0.6	0.5	0.1	0.1
EBITDA [+]	-1.1	-1.0	-1.3	-0.9	-2.6	-0.6
EBITDA growth	24.8%	-62.8%	111.4%
Depreciation and amortization	0.0	0.0	0.0	0.0	0.0	0.0
EBIT [+]	-1.1	-1.0	-1.3	-0.9	-2.6	-0.6
EBIT growth	24.7%	-62.8%	111.4%
Non-recurring items [+]						0.0
Asset impairment						0.0
Interest expense	0.3	0.3	0.1		0.0	0.2
Interest expense	0.3	0.3	0.1		0.0	0.2
Other income (expense), net [+]	0.0		0.0	-0.1
Gain (loss) on debt retirement				0.1
Other non-operating income	0.0
Other	0.0	-0.3	-0.1		0.0	-0.2
Pre-tax income	-1.4	-1.3	-1.4	-1.0	-2.6	-0.8
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-1.4	-1.3	-1.4	-1.4	-3.2	-0.8

Basic EPS [+]	($0.99)	($0.90)		($1.00)	($2.39)
Growth	-0.9%	-62.3%
Diluted EPS [+]	($0.99)	($0.90)		($1.00)	($2.39)
Growth	-0.9%	-62.3%

Shares outstanding (basic) [+]	1.4	1.4		1.4	1.3
Growth	5.7%	8.0%
Shares outstanding (diluted) [+]	1.4	1.4		1.4	1.3
Growth	5.7%	8.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.